Today: 19 May 2026
Browse Category

LSE:FRES 9 October 2025 - 2 December 2025

Fresnillo PLC Stock Soars 325% in 2025: Price Today, Probe Gold Deal and 2026 Forecasts

Fresnillo PLC Stock Soars 325% in 2025: Price Today, Probe Gold Deal and 2026 Forecasts

Fresnillo shares traded at 2,754p in London on 2 December 2025, up 325% from a 2024 low of 612p, after hitting a 52-week high of 2,850p the day before. The company’s market value stands near £19.4bn, with a trailing P/E of 56 and a 1.3% dividend yield. The surge follows record gold and silver prices and a major Canadian acquisition. Technical models classify the stock as a “Buy or Hold.”
2 December 2025
····
UK Stock Market Today: FTSE 100 Slips as Risk-Off Mood Starts December in London

UK Stock Market Today: FTSE 100 Slips as Risk-Off Mood Starts December in London

The FTSE 100 slipped 0.1–0.2% to around 9,700 by early afternoon in London on December 1, while the FTSE 250 dropped 0.8%, its sharpest fall in two weeks. Mining stocks climbed over 5% as gold and silver prices rose, but aerospace, defence, and major banks declined. Homebuilders in the FTSE 250 fell more than 1.5% amid concerns over higher borrowing costs and weak services data.
1 December 2025
·······
UK Stock Market Today: FTSE 100 Flat, Mid‑Caps Slide as Risk‑Off Mood Opens December – 1 December 2025

UK Stock Market Today: FTSE 100 Flat, Mid‑Caps Slide as Risk‑Off Mood Opens December – 1 December 2025

The FTSE 100 held near record highs on Monday, trading at 9,718 by early afternoon, down just 0.03%. The FTSE 250 slid 0.8%, its sharpest fall in two weeks, as investors sold off mid-cap and cyclical stocks. Gold miners surged more than 5% as bullion hit a six-week high. Rolls-Royce fell 3%, while HICL Infrastructure rose 4.4%.
1 December 2025
········
Fresnillo PLC Stock Forecast 2026: Can the Silver Miner Sustain Its 2025 Breakout?

Fresnillo PLC Stock Forecast 2026: Can the Silver Miner Sustain Its 2025 Breakout?

Fresnillo PLC shares have more than tripled in 2025, hitting fresh 52-week highs above 2,770p in London and $36 on U.S. OTC markets as of December 1. The surge follows record gold and silver prices, with gold topping $4,000/oz and silver above $53/oz this year. Fresnillo’s American depositary shares rose over 325% since late 2024, far outpacing major indices.
1 December 2025
··
FTSE 100’s Record Run: Inside London’s Blue-Chip Rally and What’s Next

FTSE 100 Jumps on US Shutdown Hopes as Diageo Soars; BoE Stablecoin Plan and Gold Rally Lift London Stocks — UK Market Wrap (10 November 2025)

FTSE 100 rose about 1% to near 9,780 by late morning, lifted by Diageo’s 7–8% surge after naming Sir Dave Lewis as CEO and a rally in gold miners as spot gold hit $4,070/oz. Gains tracked a European rebound after US Senate steps to end the government shutdown. UK 10-year gilt yields edged up to 4.49%. Sterling held steady at $1.3175.
10 November 2025
····
FTSE 100’s Record Run: Inside London’s Blue-Chip Rally and What’s Next

FTSE 100 Roars into November: Oil Windfall, Gold Surge & Rate Cut Hopes Drive Rally

The FTSE 100 opened up 0.2% at 9,738 on November 3, holding near record highs as oil and gold prices surged. BP gained after a $1.5 billion U.S. pipeline sale, while Vodafone fell up to 3% on a UBS downgrade. UK bank shares hit their highest since 2008. Manufacturing PMI rose to 49.7, its best in a year, ahead of the Bank of England’s rate decision this week.
3 November 2025
···········
FTSE 100’s Record Run: Inside London’s Blue-Chip Rally and What’s Next

FTSE 100’s Record Run: Inside London’s Blue-Chip Rally and What’s Next

The FTSE 100 closed at a record high near 9,548 in early October, up 15–17% year-to-date, led by surges in banks, miners, and healthcare stocks. Gains followed strong earnings, regulatory relief, and gold topping $4,000/oz. A weak pound boosted international firms’ profits. Political shifts and a new UK-India trade deal also moved markets, while Middle East tensions kept oil and gold prices elevated.
9 October 2025
······
1 2

Stock Market Today

  • When Will Island Pharmaceuticals Limited (ASX:ILA) Reach Profitability?
    May 19, 2026, 3:26 AM EDT. Island Pharmaceuticals Limited (ASX:ILA), a drug repurposing company focusing on antiviral therapeutics in Australia and the U.S., posted a AU$3.9 million loss in the latest financial year and a AU$7.2 million loss over the trailing twelve months. Analysts project the company will break even in 2027 and reach a profit of AU$295 million by 2028. This forecast implies an ambitious average annual growth rate of 140%. Notably, Island Pharmaceuticals operates with no debt, relying solely on shareholder funding, which reduces financial risk typical in cash-burning pharmaceutical firms. Investors anticipate milestone developments but should remain cautious of the high growth assumptions given the volatile nature of pharmaceutical cash flows during drug development phases.

Latest articles

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

19 May 2026
Dominion Energy shares jumped 9.4% after agreeing to an all-stock merger with NextEra Energy, whose shares fell 4.6%. The S&P 500 slipped 0.1% and the Nasdaq dropped 0.5% as investors sold technology stocks amid rising Treasury yields and oil prices. Nvidia fell 1.4% ahead of earnings. U.S. crude settled at $107.37, and the 10-year Treasury yield reached 4.59%.
XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

19 May 2026
XP Inc.’s U.S.-listed shares fell 3.78% in after-hours trading Monday after reporting higher Q1 profit but weaker net inflows and a lower retail take rate. Net income rose 7% to 1.32 billion reais, but net inflow dropped to 14 billion reais from 24 billion a year earlier. The company declared a $0.20 dividend and announced a new CFO, Gustavo Alejo Viviani, starting August 3.
LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

19 May 2026
Publicis Groupe agreed to buy LiveRamp Holdings for $38.50 a share in cash, valuing the U.S. data-collaboration firm at $2.546 billion. LiveRamp stock jumped to $37.77 on the news, while the broader market fell. LiveRamp reported fiscal Q4 revenue of $206 million, up 9% from a year earlier. Publicis said the deal will boost its adjusted earnings per share from the first year after closing.

Popular

Ondas Shares Drop Following $199 Million AI Defense Deal, Traders Eye Next Steps

Ondas Shares Drop Following $199 Million AI Defense Deal, Traders Eye Next Steps

18 May 2026
Ondas Inc. shares dropped about 10% to $9.555 in midday Nasdaq trading Monday after announcing a $199 million all-stock acquisition of Israeli defense software firm Omnisys and filing for potential resale of over 2.2 million shares tied to a previous deal. Trading volume topped 48 million shares. The Omnisys deal is expected to close in Q2, pending approvals and retention of key staff.
Go toTop